Differentiation of adipose-derived stem cells into Schwann cell phenotype induces expression of P2X receptors that control cell death
Open Access
- 25 July 2013
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 4 (7) , e743
Abstract
Schwann cells (SCs) are fundamental for development, myelination and regeneration in the peripheral nervous system. Slow growth rate and difficulties in harvesting limit SC applications in regenerative medicine. Several molecules, including receptors for neurosteroids and neurotransmitters, have been suggested to be implicated in regulating physiology and regenerative potential of SCs. Adipose-derived stem cells (ASCs) can be differentiated into SC-like phenotype (dASC) sharing morphological and functional properties with SC, thus representing a valid SC alternative. We have previously shown that dASC express γ-aminobutyric-acid receptors, which modulate their proliferation and neurotrophic potential, although little is known about the role of other neurotransmitters in ASC. In this study, we investigated the expression of purinergic receptors in dASC. Using reverse transriptase (RT)-PCR, western blot analyses and immunocytochemistry, we have demonstrated that ASCs express P2X3, P2X4 and P2X7 purinoceptors. Differentiation of ASCs towards glial phenotype was accompanied by upregulation of P2X4 and P2X7 receptors. Using Ca2+-imaging techniques, we have shown that stimulation of purinoceptors with adenosine 5′-triphosphate (ATP) triggers intracellular Ca2+ signals, indicating functional activity of these receptors. Whole-cell voltage clamp recordings showed that ATP and BzATP induced ion currents that can be fully inhibited with specific P2X7 antagonists. Finally, using cytotoxicity assays we have shown that the increase of intracellular Ca2+ leads to dASC death, an effect that can be prevented using a specific P2X7 antagonist. Altogether, these results show, for the first time, the presence of functional P2X7 receptors in dASC and their link with critical physiological processes such as cell death and survival. The presence of these novel pharmacological targets in dASC might open new opportunities for the management of cell survival and neurotrophic potential in tissue engineering approaches using dASC for nerve repair.Keywords
This publication has 62 references indexed in Scilit:
- GABA-B receptors in the PNS have a role in Schwann cells differentiation?Frontiers in Cellular Neuroscience, 2013
- Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and deathPurinergic Signalling, 2012
- Use of adipose-derived stem cells to fabricate scaffoldless tissue-engineered neural conduits in vitroNeuroscience, 2012
- Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseasesAdvanced Biomedical Research, 2012
- Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and deathCell Death & Disease, 2010
- Practical considerations concerning the use of stem cells for peripheral nerve repairNeurosurgical Focus, 2009
- Peripheral nerve regeneration by the in vitro differentiated-human bone marrow stromal cells with Schwann cell propertyBiochemical and Biophysical Research Communications, 2007
- Kinetics of ATP release following compression injury of a peripheral nerve trunkPurinergic Signalling, 2006
- Purinergic signalling in neuron–glia interactionsNature Reviews Neuroscience, 2006
- Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neuronesThe Journal of Physiology, 1999